Biomedical scientist graduated from Unimetrocamp in 2019, with a technical degree in Biotechnology from ETECAP (20142015). She is currently completing a direct PhD in the Graduate Program in Pharmaceutical Sciences at Unicamp (2020present), with her research conducted at the Brazilian Center for Research in Energy and Materials (CNPEM). Her work focuses on the validation of therapeutic targets in Trypanosoma cruzi, with emphasis on three enzymes: G6PDH, malic enzyme, and TDH. She has experience in molecular biology, protein purification, mammalian and parasite cell culture, with a strong focus on drug discovery. During her PhD, she has employed approaches such as drug resistance induction, phenotypic assays for compound screening and characterization, NMR-based metabolomics, RNA-seq, DNA sequencing, and mitochondrial respiration analysis using the Oroboros system. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chagas Disease (CD) caused by Trypanosoma cruzi is a public health problem in Latin America. Despite killing thousands of people every year and be expanding to other continents, CD treatment boils down to a single drug with inadequate safety profile and efficacy. One of the difficulties in developing new medicines for CD is related to the scarcity of validated targets for the development …
| 2 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID